Fulgent Genetics, Inc. (FLGT)
19.71
+0.26
(+1.34%)
USD |
NASDAQ |
Aug 25, 13:00
Fulgent Genetics Total Assets (Quarterly) : 1.089B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.089B |
| March 31, 2026 | 1.156B |
| December 31, 2025 | 1.214B |
| September 30, 2025 | 1.215B |
| June 30, 2025 | 1.200B |
| March 31, 2025 | 1.206B |
| December 31, 2024 | 1.257B |
| September 30, 2024 | 1.234B |
| June 30, 2024 | 1.232B |
| March 31, 2024 | 1.230B |
| December 31, 2023 | 1.273B |
| September 30, 2023 | 1.358B |
| June 30, 2023 | 1.355B |
| March 31, 2023 | 1.377B |
| December 31, 2022 | 1.436B |
| September 30, 2022 | 1.406B |
| June 30, 2022 | 1.462B |
| March 31, 2022 | 1.466B |
| December 31, 2021 | 1.297B |
| September 30, 2021 | 1.205B |
| June 30, 2021 | 1.050B |
| March 31, 2021 | 999.08M |
| Date | Value |
|---|---|
| December 31, 2020 | 705.66M |
| September 30, 2020 | 247.31M |
| June 30, 2020 | 95.92M |
| March 31, 2020 | 89.32M |
| December 31, 2019 | 89.84M |
| September 30, 2019 | 61.14M |
| June 30, 2019 | 56.44M |
| March 31, 2019 | 55.65M |
| December 31, 2018 | 54.62M |
| September 30, 2018 | 54.85M |
| June 30, 2018 | 55.55M |
| March 31, 2018 | 55.44M |
| December 31, 2017 | 58.00M |
| September 30, 2017 | 58.67M |
| June 30, 2017 | 58.80M |
| March 31, 2017 | 58.82M |
| December 31, 2016 | 58.04M |
| September 30, 2016 | 22.76M |
| June 30, 2016 | 26.78M |
| March 31, 2016 | |
| December 31, 2015 | 5.832M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 16.94B |
| Labcorp Holdings, Inc. | 18.53B |
| OPKO Health, Inc. | 1.829B |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 1.352B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 93.24M |
| Shareholders Equity (Quarterly) | 1.002B |
| Debt to Equity Ratio | 0.0096 |
| Current Ratio | 6.338 |
| Net Debt Paydown Yield | -0.05% |